Outlook Therapeutics CEO Lawrence Kenyon's 2020 pay falls 36% to $1.2M
Outlook Therapeutics reports 2020 executive compensation
By ExecPay News
Published: February 22, 2021
Outlook Therapeutics reported fiscal year 2020 executive compensation information on February 22, 2021.
In 2020, three executives at Outlook Therapeutics received on average a compensation package of $501K, a 73% decrease compared to previous year.
Lawrence A. Kenyon, Chief Executive Officer, received $1.2M in total, which decreased by 36% compared to 2019. 52% of Kenyon's compensation, or $621K, was in option awards. Kenyon also received $117K in bonus, $425K in salary, as well as $21K in other compensation.
Terry Dagnon, Chief Operating Officer, received a compensation package of $160K. 100% of the compensation package, or $160K, was in other compensation.
Jeff Evanson, Chief Commercial Officer, earned $160K in 2020.
Outlook Therapeutics' fiscal year ends on September 30.